Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1993-05-06
1995-04-04
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540495, 540506, 540523, A61K 3155, C07D22316
Patent
active
054038367
ABSTRACT:
A benzazepine derivative that acts as a nonpeptidyl platelet aggregation inhibitor is provided. This inhibitor potently inhibits fibrinogen binding to the GPII.sub.b III.sub.a receptor and is provided in therapeutic compositions for the treatment of diseases for which blocking platelet aggregation is indicated. These nonpeptidyl inhibitors are provided in combination with thrombolytics and anticoagulants.
REFERENCES:
patent: 3371085 (1968-02-01), Reeder et al.
patent: 3374264 (1968-03-01), Uskokovic et al.
patent: 3415814 (1968-12-01), Carabateas
patent: 3551414 (1970-12-01), Hawthorne et al.
patent: 3721666 (1973-03-01), Weber et al.
patent: 4689326 (1987-08-01), Hall et al.
patent: 5055464 (1991-10-01), Murakami et al.
patent: 5061693 (1991-10-01), Nutt et al.
patent: 5063225 (1991-11-01), Clemence et al.
patent: 5082937 (1992-01-01), Calvet et al.
Kukla, M. J. et al., "Synthesis and Anti-HIV-1 Activity of 4,5,6,7-Tetrahydro-5-methylimidazo [4,5,lk][1,4]benzodiazepin-2(1H)-one(TIBO) Derivatives. 2", J. Med. Chem., 34:3187-3197 (1991).
Watjen et al., "Novel Benzodiazepine Receptor Partial Agonists: Oxadiazolylimidazobenzodiazepines", J. Med. Chem. 3:2282-2291 (1989).
Lee, C. M. "Synthesis of 1-Methyl-3H-1,4-benzodiazepine-2,5 (1H,4H)-dione and Derivatives", J. Heterocyclic Chem. 1:235 (1964).
Venuti, M. C., "Isatoic Anhydride/4-Dimethylaminopyridine as Reagent for ortho-Aminobenzoylation", Synthesis 266-268 (1982).
CAS Substructure Search, Dec. 5, 1991.
Voorstad et al., "Comparison of the Hypolipidemic Activity of Cyclic v. Acyclic Imides", J. Med. Chem., 28:9-12 (1985).
Catsoulacos, P. Chemical Abstracts, abstract No. 115543c, 79: 356 (1973).
Nagarajan et al., Chemical Abstracts, abstract No. 136120u, 84: 423 (1974).
Oine et al., Chemical Abstracts, abstract no. 91597m, 84: 473 (1974).
Boehringer C. H., Chemical Abstracts, abstract No. 18778a, 79: 423 (1973).
Griot, Rudolf G., Chemical Abstracts, abstract No. 47512d, 70: 348 (1969).
Carabateas, Philip M., Chemical Abstracts, abstract No. 47513e, 70: 348 (1969).
Thomae, Dr. Karl, Chemical Abstracts, abstract No. 47516h, 70:348 (1969).
Shirai et al., Chemical Abstracts, abstract No. 140001r, 77: 444 (1972).
Levai et al., Chemical Abstracts, abstract No. 6376g, 90: 348 (1979).
Shirai et al., Chemical Abstracts, abstract No. 34228q, 76: 318 (1972).
Coppola, Gary M., "The Chemistry of Isatoic Anydride", Synthesis, ed. Verlag, Georg Thieme, pp. 505-536 (1980).
CAS Substructure Search, Dec. 12, 1991, Blackburn et al.
Kim et al., Tetrahedron Lett. 3183-3186 (1988).
Murai, T. et al., Tetrahedron Lett. 26: 5145-5148 (1985).
Bellamy et al., Tetrahydron Lett. 25(8): 839-842 (1984).
Kappe, T. and Stadlbauer, "Isatoic Andrides and Their Uses in Heterocyclic Synthesis", Advances in Heterocyclic Chemistry, 28:127-182 (1981).
Voorstad et al., J. Med. Chem., 28: 9-12 (1985).
Blackburn Brent
Gadek Thomas
McDowell Robert
Webb Rob
Datlow Philip I.
Genentech Inc.
Shah Mukund J.
Winter Daryl B.
LandOfFree
Benzazepine platelet aggregation inhibitors having specificity f does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzazepine platelet aggregation inhibitors having specificity f, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzazepine platelet aggregation inhibitors having specificity f will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2380801